Literature DB >> 19561137

Adiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease.

Ross Summer1, Christopher A Fiack, Yasumasa Ikeda, Kaori Sato, Daniel Dwyer, Noriyuki Ouchi, Alan Fine, Harrison W Farber, Kenneth Walsh.   

Abstract

Adiponectin (APN) is an adipocyte-derived factor that exists at high concentrations in serum and has anti-inflammatory and systemic vascular-protective properties. In this study, we investigated the role of APN in pulmonary vascular homeostasis. We found that APN localizes to the luminal side of blood vessels in lung and acts in vitro to block TNF-alpha-induced E-selectin upregulation in pulmonary artery endothelial cells. Targeted deletion of the APN gene in mice leads to a vascular phenotype in lung characterized by E-selectin upregulation and age-dependent increases in perivascular inflammatory cell infiltration and pulmonary arterial pressures. Taken together, these findings demonstrate an important role for APN in lung vascular homeostasis and suggest that APN-deficient states may contribute to the pathogenesis of inflammatory pulmonary vascular disease and to the development of pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561137      PMCID: PMC2739777          DOI: 10.1152/ajplung.90599.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  24 in total

1.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

Authors:  Yukihiro Takemura; Noriyuki Ouchi; Rei Shibata; Tamar Aprahamian; Michael T Kirber; Ross S Summer; Shinji Kihara; Kenneth Walsh
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

2.  A novel role for adiponectin in the regulation of inflammation.

Authors:  Noriyuki Ouchi; Kenneth Walsh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07       Impact factor: 8.311

3.  Adiponectin inhibits endothelial synthesis of interleukin-8.

Authors:  Chikaaki Kobashi; Masaharu Urakaze; Mika Kishida; Etsuko Kibayashi; Hideki Kobayashi; Shinji Kihara; Tohru Funahashi; Michiyo Takata; Rie Temaru; Akira Sato; Katsuya Yamazaki; Norio Nakamura; Masashi Kobayashi
Journal:  Circ Res       Date:  2005-11-03       Impact factor: 17.367

4.  Adiponectin replenishment ameliorates obesity-related hypertension.

Authors:  Koji Ohashi; Shinji Kihara; Noriyuki Ouchi; Masahiro Kumada; Koichi Fujita; Aki Hiuge; Toshiyuki Hibuse; Miwa Ryo; Hitoshi Nishizawa; Norikazu Maeda; Kazuhisa Maeda; Rei Shibata; Kenneth Walsh; Tohru Funahashi; Iichiro Shimomura
Journal:  Hypertension       Date:  2006-05-01       Impact factor: 10.190

5.  High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells.

Authors:  Yoshiyuki Hattori; Yasuko Nakano; Sachiko Hattori; Atsuko Tomizawa; Kouichi Inukai; Kiuo Kasai
Journal:  FEBS Lett       Date:  2008-05-01       Impact factor: 4.124

6.  Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms.

Authors:  Masaki Nishimura; Yasuhiro Izumiya; Akiko Higuchi; Rei Shibata; Jianhua Qiu; Chiho Kudo; Hwa Kyoung Shin; Michael A Moskowitz; Noriyuki Ouchi
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

7.  Adiponectin ameliorates hypoxia-induced pulmonary arterial remodeling.

Authors:  Yasuhiko Nakagawa; Ken Kishida; Shinji Kihara; Tohru Funahashi; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2009-03-09       Impact factor: 3.575

8.  Adiponectin promotes revascularization of ischemic muscle through a cyclooxygenase 2-dependent mechanism.

Authors:  Koji Ohashi; Noriyuki Ouchi; Kaori Sato; Akiko Higuchi; Tomo-o Ishikawa; Harvey R Herschman; Shinji Kihara; Kenneth Walsh
Journal:  Mol Cell Biol       Date:  2009-04-27       Impact factor: 4.272

9.  Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice.

Authors:  R Summer; F F Little; N Ouchi; Y Takemura; T Aprahamian; D Dwyer; K Fitzsimmons; B Suki; H Parameswaran; A Fine; K Walsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-03-07       Impact factor: 5.464

10.  Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling.

Authors:  Benjamin D Medoff; Yoshihisa Okamoto; Patricio Leyton; Meiqian Weng; Barry P Sandall; Michael J Raher; Shinji Kihara; Kenneth D Bloch; Peter Libby; Andrew D Luster
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

View more
  57 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

Review 2.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

3.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

4.  C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury.

Authors:  Dilip Shah; Freddy Romero; Ying Zhu; Michelle Duong; Jianxin Sun; Kenneth Walsh; Ross Summer
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

5.  Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure.

Authors:  Allan J Walkey; Todd W Rice; Jason Konter; Noriyuki Ouchi; Rei Shibata; Kenneth Walsh; Bennett P deBoisblanc; Ross Summer
Journal:  Crit Care Med       Date:  2010-12       Impact factor: 7.598

6.  Unrecognized glucose intolerance is common in pulmonary arterial hypertension.

Authors:  Meredith E Pugh; Ivan M Robbins; Todd W Rice; James West; John H Newman; Anna R Hemnes
Journal:  J Heart Lung Transplant       Date:  2011-04-13       Impact factor: 10.247

7.  Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis.

Authors:  Luca Vanella; Martina Canestraro; Craig R Lee; Jian Cao; Darryl C Zeldin; Michal L Schwartzman; Nader G Abraham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-04-20       Impact factor: 3.072

8.  Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice.

Authors:  Ming Zhu; Christopher Hug; David I Kasahara; Richard A Johnston; Alison S Williams; Norah G Verbout; Huiqing Si; Jordan Jastrab; Amit Srivastava; Erin S Williams; Barbara Ranscht; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-13       Impact factor: 6.914

9.  Endothelial GATA-6 deficiency promotes pulmonary arterial hypertension.

Authors:  Angela Ghatnekar; Izabela Chrobak; Charlie Reese; Lukasz Stawski; Francesca Seta; Elaine Wirrig; Jesus Paez-Cortez; Margaret Markiewicz; Yoshihide Asano; Russell Harley; Richard Silver; Carol Feghali-Bostwick; Maria Trojanowska
Journal:  Am J Pathol       Date:  2013-04-11       Impact factor: 4.307

10.  Vascular remodeling mediated by Angptl2 produced from perivascular adipose tissue.

Authors:  Ippei Shimizu; Kenneth Walsh
Journal:  J Mol Cell Cardiol       Date:  2013-03-23       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.